Product Introduction
Palnox 0.25mg Injection is an antiemetic medication containing Palonosetron Hydrochloride. It is primarily used to prevent nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures. It works by blocking serotonin receptors that trigger the vomiting reflex in the brain and gastrointestinal tract.
Uses
-
Prevention of nausea and vomiting caused by chemotherapy (acute and delayed phases)
-
Management of radiotherapy-induced nausea and vomiting
-
Prevention of postoperative nausea and vomiting (PONV)
Benefits
-
Long-lasting relief: Provides effective control of nausea and vomiting for up to several days
-
Rapid onset: Begins working quickly when administered before chemotherapy or surgery
-
Improves patient comfort: Helps maintain hydration, nutrition, and treatment compliance
-
Minimal sedation: Does not usually cause drowsiness or sedation
Composition
-
Active Ingredient: Palonosetron Hydrochloride 0.25mg per vial
Side Effects
-
Headache
-
Constipation
-
Dizziness
-
Injection site reactions such as redness or pain
-
Rare allergic reactions like rash, swelling, or difficulty breathing
Safety Advice
-
For intravenous use only, under medical supervision
-
Not to be self-administered
-
Use with caution in pregnant or breastfeeding women – only under medical advice
-
May cause dizziness – avoid driving or operating machinery until effects are known
-
Store below 30°C, protected from light and moisture
-
Keep out of reach of children
Palnox 0.25mg Injection is a reliable and well-tolerated solution for managing nausea and vomiting, especially in patients undergoing cancer treatments or surgery.
